Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Ensituximab |
Trade Name | |
Synonyms | NEO-102 |
Drug Descriptions |
Ensituximab (NEO-102) is a monoclonal antibody against a form of Muc5ac expressed in pancreatic and colorectal cancers, which may induce cytotoxic immune response against tumor cells (PMID: 27449137, PMID: 32303539). |
DrugClasses | |
CAS Registry Number | 1092658-06-4 |
NCIT ID | C90532 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ensituximab | Ensituximab | 0 | 0 |